We anticipate our next request for applications (RFA) will be available in 2025 to fund up to two projects
Previous Proposals
Enhancing CNS delivery of therapeutic agents
Proposal due date: February 2, 2024 at 5 p.m.
Early phase drug development support program
Proposal due date: February 2, 2024 at 5 p.m.